EUVIMEDEUVIMED entdecken
Crossref

Imageable Brachytherapy with Chelator‐Free Radiolabeling Hydrogel

Zhencun Cui, Liqin Wang, Wei Liu, Dan Xu, Taofeng Zhang, Baoliang Ma, Kai Zhang, Lingyan Yuan, Zhitong Bing, Jiangyan Liu, Bin Liu iD, Wangsuo Wu und 1 weitere

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202401438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Zhencun Cui und 12 weiteren Autor:innen. Beteiligte Einrichtung: MOE Frontiers Science Center for Rare Isotopes, Lanzhou University, 222 Tianshui South Road, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: Brachytherapy, Hydrogels. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brachytherapy stands as an essential clinical approach for combating locally advanced tumors. Here, an injectable brachytherapy hydrogel is developed for the treatment of both local and metastatic tumor. Fe‐tannins nanoparticles are efficiently and stably radiolabeled with clinical used therapeutic radionuclides (such as 131 I, 90 Y, 177 Lu, and 225 Ac) without a chelator, and then chemically cross‐linked with 4‐armPEG‐SH to form brachytherapy hydrogel. Upon intratumoral administration, magnetic resonance imaging (MRI) signal from ferric ions embedded within the hydrogel directly correlates with the retention dosage of radionuclides, which can real‐time monitor radionuclides emitting short‐range rays in vivo without penetration limitation during brachytherapy. The hydrogel's design ensures the long‐term tumor retention of therapeutic radionuclides, leading to the effective eradication of local tumor. Furthermore, the radiolabeled hydrogel is integrated with an adjuvant to synergize with immune checkpoint blocking therapy, thereby activating potent anti‐tumor immune responses and inhibiting metastatic tumor growth. Therefore, this work presents an imageable brachytherapy hydrogel for real‐time monitoring therapeutic process, and expands the indications of brachytherapy from treatment of localized tumors to metastatic tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyHydrogelsAnimalsMiceMagnetic Resonance ImagingHumansCell Line, TumorFemaleNanoparticlesChelating AgentsIodine RadioisotopesMice, Inbred BALB CRadioisotopes

Stichwörter der Autor:innen

biomaterialsbrachytherapychelator‐free radiolabelinghydrogel

Substanzen

HydrogelsChelating AgentsIodine RadioisotopesRadioisotopes

Autor:innen und Institutionen

  • MOE Frontiers Science Center for Rare Isotopes, Lanzhou University, 222 Tianshui South Road, Lanzhou, 730000, China.
  • School of Nuclear Science and Technology, Lanzhou University, 222 Tianshui South Road, Lanzhou, 730000, China.
  • Department of Nuclear Medicine, Second Hospital of Lanzhou University, 82 Cuiying Gate, Lanzhou, 730000, China.
  • Key Laboratory of Heavy Ion Radiation Medicine, Institute of Modern Physics, Chinese Academy of Sciences, 509 Nanchang Road, Lanzhou, 730000, China.
  • School of Life Science and Engineering, Lanzhou University of Technology, 287 Langongping Road, Lanzhou, 730000, China.
  • School of Stomatology, Lanzhou University, 199 Donggang West Road, Lanzhou, 730000, China.

ORCID-Profile: Bin Liu, Longlong Tian

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Lanzhou Youth Science and Technology Talent Innovation Project
  • Science and Technology Program of Gansu Province
  • National Key Research and Development Program of China

Zitieren

APA

Cui, Z., Wang, L., Liu, W., Xu, D., Zhang, T., Ma, B., Zhang, K., Yuan, L., Bing, Z., Liu, J., Liu, B., Wu, W., & Tian, L. (2024). Imageable Brachytherapy with Chelator‐Free Radiolabeling Hydrogel. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401438

Vancouver

Cui Z, Wang L, Liu W, Xu D, Zhang T, Ma B, et al. Imageable Brachytherapy with Chelator‐Free Radiolabeling Hydrogel. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401438

BibTeX
@article{Cui2024,
  author = {Cui, Zhencun and Wang, Liqin and Liu, Wei and Xu, Dan and Zhang, Taofeng and Ma, Baoliang and Zhang, Kai and Yuan, Lingyan and Bing, Zhitong and Liu, Jiangyan and Liu, Bin and Wu, Wangsuo and Tian, Longlong},
  title = {Imageable Brachytherapy with Chelator‐Free Radiolabeling Hydrogel},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202401438}
}
Kostenlos starten →